Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
about
Trio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayersCrystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyTy3 capsid mutations reveal early and late functions of the amino-terminal domainAssociation of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayCharacterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.RNA trafficking signals in human immunodeficiency virus type 1.Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysisAnalysis of the initiating events in HIV-1 particle assembly and genome packagingFunctional characterization of the human immunodeficiency virus type 1 genome by genetic footprintingEvidence for direct involvement of the capsid protein in HIV infection of nondividing cells.Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domainCells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin AA putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assemblyCryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assemblyThe cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes.Effects of Gag mutation and processing on retroviral dimeric RNA maturation.A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.Biophysical characterization of the feline immunodeficiency virus p24 capsid protein conformation and in vitro capsid assembly.Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.Extreme genetic fragility of the HIV-1 capsid.Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication.In vitro analysis of human immunodeficiency virus particle dissociation: gag proteolytic processing influences dissociation kinetics.Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particlesCyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcriptionCharacterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycleIntrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
P2860
Q27676343-AED6CA0A-496C-42A9-9173-DE65B66EC557Q27732646-F9A60DD3-75B2-4532-ABC1-CA9ABF0BED33Q27931343-16F0BB53-6C24-427D-9676-1B022FA94352Q30447057-894C2048-58EC-43CA-B238-A47088946C48Q30452616-8E40FB12-5C81-4EC7-A107-020E7FCB3EFEQ30453555-33334C84-29D7-4C56-BEC6-D70E9300F91EQ30855134-F3D0E988-4B96-4C73-8090-785D821D8848Q30992792-917127E1-B2A7-4B0B-90D7-34FD28AE85A1Q31523975-19F77700-E56E-4425-8E67-3934C7878F44Q33304219-D9BF62D4-F79D-4584-A607-912FD8FE6027Q33718140-FB7435B4-10CC-469B-B16F-E9258F40CECBQ33781971-734F343A-7971-431D-BDEA-D5663B6D223CQ33782377-8F4117EA-0032-449C-AC9C-CFACCBA67835Q33782886-B5E5ED06-3030-43FD-A446-32A800D23D6AQ33783955-2E0A2C4B-D33D-4707-B730-D44D842AD802Q33784754-C5DBEB75-01CA-4CCC-A061-3314E4057DDBQ33785479-1198DA84-7EF8-44CF-827D-54E527E48CE7Q33787084-040B2388-F275-4290-A7B9-F91F5D76981FQ33794223-3A938A93-C9B2-47B5-8A04-BE82111F717EQ33805303-F64CA54C-A5F8-4CF2-ACA6-7DCC00562106Q33820522-CBCC28F3-78B6-4CE5-997A-DC2FA43C7BBDQ33845811-BE1380CA-3198-4CDF-AC1B-5A3D4A4A9CD6Q34141649-33409ED2-5BEA-442A-8EAA-4BD154F1314EQ34142733-130F0E89-76B4-4A36-9F8D-AFC4BBC78CA3Q34189436-F2595022-F3D0-4320-B098-CFE14C3B5ED4Q34302140-A5BA32CB-3883-42BF-A691-01499D3ADF53Q34434813-D956F447-DC58-4607-8F31-38F95F3D6359Q34606804-E2397F37-8339-4B70-9453-F856A8551477Q34684340-BCCF2518-DFBB-4E31-BAF9-03DAAF4DB30FQ34717899-EF41E1C5-632D-4ED8-9A05-B8B1634F4F91Q34789351-2B896A54-37A5-4CB3-B8DE-DC39C705E67AQ35104668-90485300-6D2E-4725-8F88-0756648196ABQ35184863-638F7827-9196-4567-9F1C-3D293A7787DDQ35840003-5CB2EF18-482F-493E-B33F-F4F698B34041Q35857486-E4A42825-BC2C-4426-B85B-C32816718D00Q35861172-98815FBE-273E-4A0A-BC51-211C111355BCQ35864074-D554A4E4-568A-4EE5-8BA7-2F7132833F41Q35873645-72CB2F05-4F24-4766-93E7-D2AF5E2CF97BQ35874055-73ADB962-B90D-4A09-8EB9-9E387940A260Q35882404-3DD56E63-A153-4ADF-9509-67752A7E7F9A
P2860
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Linker insertion mutations in ...... bly, release, and infectivity.
@ast
Linker insertion mutations in ...... bly, release, and infectivity.
@en
type
label
Linker insertion mutations in ...... bly, release, and infectivity.
@ast
Linker insertion mutations in ...... bly, release, and infectivity.
@en
prefLabel
Linker insertion mutations in ...... bly, release, and infectivity.
@ast
Linker insertion mutations in ...... bly, release, and infectivity.
@en
P2093
P2860
P1433
P1476
Linker insertion mutations in ...... mbly, release, and infectivity
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z